|
A more recent version of this article appeared on May 1, 2004
Papers In Press, published online ahead of print February 16, 2004
J. Lipid Res., doi:10.1194/jlr.M300508-JLR200
Submitted on December 11, 2003
Revised on January 14, 2004
Accepted on January 27, 2004
Fatty liver in familial hypobetalipoproteinemia: roles of the APOB defects, intra-abdominal adipose tissue, and insulin sensitivity
Tariq Tanoli, Pin Yue, Dmitriy Yablonskiy, and Gustav Schonfeld
Endocrinology, Diabetes & Lipid Research, Washington University School of Medicine, St Louis, MI 63110
Corresponding Author: gschonfe{at}im.wustl.edu
Fatty liver is frequent in the apoB-defective genetic form of familial hypobetalipoproteinemia [FHBL], but inter-individual variability in liver fat is large. To explain this, we assessed the roles of metabolic factors in 32 affected family members with apoB-defective FHBL, and 33 related and unrelated normo-lipidemic controls, matched for age, sex, and indexes of adiposity. Two-hour, 75 gm oral glucose tests, with measurements of plasma glucose and insulin levels, and body mass indexes, waist/hip ratios were obtained. Abdominal subcutaneous [SAT], intra-peritoneal [IPAT], and retro-peritoneal [RPAT] adipose masses were quantified by magnetic resonance [MR] imaging and hepatic fat by MR spectroscopy. Mean [±SD] liver fat% of FHBL and controls were 14.8±12.0 and 5.2±5.9, respectively [p=0.001]. Means for the above measures of obesity and insulin action were similar in the two groups. Important determinants of liver fat% were FHBL-affected status, IPAT, and AUC-insulin in both groups, but the strongest predictors were IPAT in FHBL [partial R2= 0.55, p<0.0002], and AUC-insulin in controls [partial R2=0.59, p=0.0001]. Regression of liver fat% on intra-peritoneal fat was significantly greater for FHBL than for controls [p<0.001]. In sum, because apoB-defective FHBL imparts heightened susceptibility to liver triglyceride accumulation, increasing IPAT and insulin resistance exert greater liver fat-raising effects in FHBL.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. van der Graaf, S. W. Fouchier, M. N. Vissers, J. C. Defesche, A. Wiegman, R. R. Sankatsing, B. A. Hutten, M. D. Trip, and J. J.P. Kastelein
Familial Defective Apolipoprotein B and Familial Hypobetalipoproteinemia in One Family: Two Neutralizing Mutations
Ann Intern Med,
May 6, 2008;
148(9):
712 - 714.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Burnett, S. Zhong, Z. G. Jiang, A. J. Hooper, E. A. Fisher, R. S. McLeod, Y. Zhao, P. H. R. Barrett, R. A. Hegele, F. M. van Bockxmeer, et al.
Missense Mutations in APOB within the beta{alpha}1 Domain of Human APOB-100 Result in Impaired Secretion of ApoB and ApoB-containing Lipoproteins in Familial Hypobetalipoproteinemia
J. Biol. Chem.,
August 17, 2007;
282(33):
24270 - 24283.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Hooper, K. Robertson, P. H. R. Barrett, K. G. Parhofer, F. M. van Bockxmeer, and J. R. Burnett
Postprandial Lipoprotein Metabolism in Familial Hypobetalipoproteinemia
J. Clin. Endocrinol. Metab.,
April 1, 2007;
92(4):
1474 - 1478.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-L. Zhang, A. Hernandez-Ono, P. Siri, S. Weisberg, D. Conlon, M. J. Graham, R. M. Crooke, L.-S. Huang, and H. N. Ginsberg
Aberrant Hepatic Expression of PPAR{gamma}2 Stimulates Hepatic Lipogenesis in a Mouse Model of Obesity, Insulin Resistance, Dyslipidemia, and Hepatic Steatosis
J. Biol. Chem.,
December 8, 2006;
281(49):
37603 - 37615.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. R. Sankatsing, S. W. Fouchier, S. de Haan, B. A. Hutten, E. de Groot, J. J.P. Kastelein, and E. S.G. Stroes
Hepatic and Cardiovascular Consequences of Familial Hypobetalipoproteinemia
Arterioscler Thromb Vasc Biol,
September 1, 2005;
25(9):
1979 - 1984.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Lin, P. Yue, Z. Chen, and G. Schonfeld
Hepatic triglyceride contents are genetically determined in mice: results of a strain survey
Am J Physiol Gastrointest Liver Physiol,
June 1, 2005;
288(6):
G1179 - G1189.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Whitfield, P. H. R. Barrett, K. Robertson, M. F. Havlat, F. M. van Bockxmeer, and J. R. Burnett
Liver Dysfunction and Steatosis in Familial Hypobetalipoproteinemia
Clin. Chem.,
January 1, 2005;
51(1):
266 - 269.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|